Plunkett Research Online: Vaccinogen Inc

VACCINOGEN INC (VGEN:GREY) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Vaccinogen Inc is a biotechnology company focused on the development and commercialization of cancer vaccines and immunotherapeutic products for cancers. Its primary product is OncoVAX, an autologous cancer vaccine indicated for the post-surgical treatment of stage II colon cancer. The OncoVAX patie.....



Vaccinogen Inc
Ticker: VGEN
Exchange: GREY
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 301 668-8400
Fax:
Address: 949 Fell Street
Baltimore, MD 21231 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Vaccines, Skin Replacement Products and Biologicals Manufacturing
ContactsDescription

Vaccinogen Inc is a biotechnology company focused on the development and commercialization of cancer vaccines and immunotherapeutic products for cancers. Its primary product is OncoVAX, an autologous cancer vaccine indicated for the post-surgical treatment of stage II colon cancer. The OncoVAX patie.....See More See More

Auditor: BDO Seidman, LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: